Federal · Amendment

Benzodiazepines and Other Targeted Substances Regulations repealed in full

Benzodiazepines and Other Targeted Substances Regulations — under the CONTROLLED DRUGS AND SUBSTANCES ACT

Recorded date: October 1, 2026
Detected: November 17, 2026. Verify commencement in the official source.

Health CareConsumer & Business

Plain-language summary · AI-assisted

The entire Benzodiazepines and Other Targeted Substances Regulations have been repealed. All detailed rules previously contained in this instrument — covering possession, test kits, dealer licences, import/export permits, pharmacist and practitioner obligations, hospital requirements, security, record-keeping, advertising, and the scheduled substance lists — are no longer in force under this regulation. Anyone who was relying on this regulation for authorizations, compliance obligations, or operational guidance should identify what framework, if any, now governs those activities. Licensed dealers, pharmacists, practitioners, and hospitals that handled benzodiazepines and other targeted substances under this regulation should seek updated guidance on their obligations.

Who this affects
licensed dealers of targeted substances · pharmacists · physicians and other practitioners · hospital administrators · importers and exporters of benzodiazepines

Check the official text
SOR/2000-217 on the official source ↗

This page isn't an official version of the law and isn't legal advice. Summaries may omit details. Verify the dates and provisions that apply to you against the official source.

View this law's change history · Follow this law by RSS

Keep up with what changes.

The free weekly digest brings together published changes across our coverage. Confirm your email to subscribe.